Furthermore, silencing of the SOX2-OT gene reduced NLRP3 inflammasome activation levels by regulating microRNA-2355-3p, thus alleviating HF symptoms and diminishing VAs (116). This evidence concerns the gene NLRP3 and hydrops fetalis.